Stealth Mode · Private Evaluation

Decoding Life via Agentic Intelligence

We are pioneering the intersection of Large Language Models and Proteomics, transforming how the world discovers life-saving drugs. Our agentic AI platform represents a paradigm shift in computational drug discovery, combining foundation models trained on billions of protein sequences with autonomous lab agents that operate 24/7.

Currently in private evaluation with Tier-1 Research Institutions, AI-in-Bio is building the future of AI-driven molecular biology. Our LLM proteomics technology enables unprecedented accuracy in drug-target interaction prediction, while our autonomous agents seamlessly bridge computational insights with physical experimentation through robotic lab automation.

SOC 2 Compliant

$50M+ in Research Grants

What is Agentic AI in Biomedicine?

Agentic AI represents the next evolution of artificial intelligence—systems that don't just analyze data, but autonomously make decisions, plan complex research strategies, and execute multi-step experiments with minimal human intervention. In drug discovery, our agentic AI platform combines LLM-driven molecular understanding with robotic lab automation to accelerate the journey from hypothesis to validated therapeutic candidate.

The Future of Drug Discovery

Our proprietary AI systems are redefining how we understand and interact with biological systems, enabling faster, more accurate computational drug discovery.

Proteomics AI

Advanced LLMs trained on 2 billion protein sequences for unprecedented protein sequence analysis and drug-target prediction accuracy.

Autonomous Agents

Self-directing autonomous lab agents that design, execute, and analyze experiments 24/7 through closed-loop optimization.

Secure Platform

Enterprise-grade security with SOC 2 certification, end-to-end encryption, and HIPAA compliance for biomedical AI applications.

Learn more about our technology platform

Ready to Transform Drug Discovery?

Join leading pharmaceutical companies and research institutions in our private evaluation program for agentic AI biomedical research.

The AI Biotech Ecosystem

Explore the broader landscape of AI-driven drug discovery, from open-source protein folding to federated learning consortia shaping the future of biomedicine.